06/02/2026
We are thrilled to announce a revolutionary new advancement for our patients living with dry Age-Related Macular Degeneration (AMD): Alcon's Valeda® Light Delivery System.
For years, the standard approach to dry AMD was a "watch and wait" mentality. Now, we are proud to offer an active, FDA-authorized treatment option that uses the power of light to protect and improve your sight.
How Valeda® Works:
Valeda utilizes Photobiomodulation (PBM)—a gentle, light-based therapy that uses precisely calibrated wavelengths of yellow, red, and near-infrared light.
Boosts Cellular Energy: The targeted light stimulates mitochondria (the "powerhouse" of the cell) to increase the production of ATP.
Reduces Inflammation: It protects retinal cells from oxidative stress, helping slow the progression of AMD.
The Benefits at a Glance:
Clinical trials have shown remarkable results, with 84% of treated patients maintaining or improving their vision over a 2-year period.
Key benefits include:
Improved Clarity: Helps enhance overall visual acuity and contrast sensitivity.
Safe & Non-Invasive: Nothing touches your eye—no lasers, no injections, no drops, and no surgery.
Completely Painless: Over 97% of patients report no treatment-related discomfort or pain.
Quick Sessions: Each in-office session takes less than 5 minutes per eye.
What to Expect:
The typical treatment schedule is quick and easy to fit into your daily life. Patients receive 9 short treatments over a 3- to 5-week period, with the series generally repeated every 4 months to maintain optimal retinal health.
Ready to Experience the Benefits?
If you or a loved one are navigating a diagnosis of dry AMD, you no longer have to simply "wait and see". It is time to take a proactive approach to your eye health.
